Markets
← Back to Stocks
STE
STERIS PLC
Health Care · Health Care Equipment
$217.94
+0.79%
Vol: 0.0M
Araverus Market Read
Thursday, March 19, 2026
Life sciences equipment supplier maintained with analyst support despite insider selling
STERIS declined 0.07% to $257.00 in after-hours trading on March 19, 2026, maintaining stability despite recent insider selling activity with significant board-level transactions on March 6, 2026. The company announced FY26 adjusted EPS guidance of $10.15-$10.30, with consensus at $10.21, providing clear earnings visibility for investors focused on healthcare and life sciences equipment markets. Piper Sandler maintains a Buy rating for STERIS, and analyst consensus shows 6 buy and 1 sell recommendation with +8.85% upside potential from current levels.
Price 50d 200d
Previous Market Reads
2 of 2 days↑
Sector Peers
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| LLYELI | $916.83 | -0.13% | -11.4% | 21.8x | 0.43 | $821.2B |
| JNJJOHNSON | $237.56 | +0.16% | -1.8% | 18.9x | 0.33 | $572.6B |
| ABBVABBVIE | $206.31 | -0.97% | -11.4% | 12.8x | 0.33 | $364.6B |
| MRKMERCK | $114.17 | -0.29% | -5.4% | 11.7x | 0.26 | $282.3B |
| UNHUNITEDHEALTH | $280.37 | -1.29% | -2.2% | 14.1x | 0.38 | $254.5B |
| AMGNAMGEN | $349.90 | -0.42% | -6.3% | 15.0x | 0.42 | $188.6B |
| ABTABBOTT | $107.19 | -1.12% | -4.5% | 17.2x | 0.74 | $186.3B |
| GILDGILEAD | $141.06 | -0.17% | -8.6% | 14.7x | 0.37 | $175.2B |
| TMOTHERMO | $470.21 | +1.18% | -6.2% | 17.5x | 0.97 | $174.7B |
Fundamentals
Market Cap$21.4B
P/E (TTM)30.4
Forward P/E19.6
Beta1.04
Div Yield114.00%
Prev Close$216.24
RSI (14-Day)
18Oversold
0305070100
52-Week Range
$204.90$217.94$269.44
From High-19.1%
From Low+6.4%
Moving Averages
50d SMA
$247.36-11.9%
200d SMA
$244.79-11.0%
Price below 200d MA — bearish structure.
Returns
1W
+2.6%
1M
-12.6%
3M
-13.7%
6M
-12.2%
1Y
-3.8%
YTD
-12.6%
Volume
Today30K
20d Avg951K
Ratio0.03x